2PHB | pdb_00002phb

An Orally Efficacious Factor Xa Inhibitor


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free: 
    0.296 (Depositor), 0.279 (DCC) 
  • R-Value Work: 
    0.260 (Depositor), 0.264 (DCC) 

wwPDB Validation 3D Report Full Report

Validation slider image for 2PHB

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

The discovery of (2R,4R)-N-(4-chlorophenyl)-N- (2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl)-4-methoxypyrrolidine-1,2-dicarboxamide (PD 0348292), an orally efficacious factor Xa inhibitor

Kohrt, J.T.Bigge, C.F.Bryant, J.W.Casimiro-Garcia, A.Chi, L.Cody, W.L.Dahring, T.Dudley, D.A.Filipski, K.J.Haarer, S.Heemstra, R.Janiczek, N.Narasimhan, L.McClanahan, T.Peterson, J.T.Sahasrabudhe, V.Schaum, R.Van Huis, C.A.Welch, K.M.Zhang, E.Leadley, R.J.Edmunds, J.J.

(2007) Chem Biol Drug Des 70: 100-112

  • DOI: https://doi.org/10.1111/j.1747-0285.2007.00539.x
  • Primary Citation Related Structures: 
    2PHB

  • PubMed Abstract: 

    Herein, we report the discovery of novel, proline-based factor Xa inhibitors containing a neutral P1 chlorophenyl pharmacophore. Through the additional incorporation of 1-(4-amino-3-fluoro-phenyl)-1H-pyridin-2-one 22, as a P4 pharmacophore, we discovered compound 7 (PD 0348292). This compound is a selective, orally bioavailable, efficacious FXa inhibitor that is currently in phase II clinical trials for the treatment and prevention of thrombotic disorders.


  • Organizational Affiliation
    • Michigan Laboratories, Ann Arbor Campus, Pfizer Global Research and Development, 2800 Plymouth Road, Ann Arbor, MI 48105, USA. jeffrey.kohrt@pfizer.com

Macromolecule Content 

  • Total Structure Weight: 32.43 kDa 
  • Atom Count: 2,314 
  • Modeled Residue Count: 285 
  • Deposited Residue Count: 285 
  • Unique protein chains: 2

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Coagulation factor X, heavy chain234Homo sapiensMutation(s): 0 
Gene Names: F10
EC: 3.4.21.6
UniProt & NIH Common Fund Data Resources
Find proteins for P00742 (Homo sapiens)
Explore P00742 
Go to UniProtKB:  P00742
PHAROS:  P00742
GTEx:  ENSG00000126218 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP00742
Sequence Annotations
Expand
Reference Sequence
Find similar proteins by:|  3D Structure
Entity ID: 2
MoleculeChains  Sequence LengthOrganismDetailsImage
Coagulation factor X, light chain51Homo sapiensMutation(s): 0 
Gene Names: F10
EC: 3.4.21.6
UniProt & NIH Common Fund Data Resources
Find proteins for P00742 (Homo sapiens)
Explore P00742 
Go to UniProtKB:  P00742
PHAROS:  P00742
GTEx:  ENSG00000126218 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP00742
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
230

Query on 230



Download:Ideal Coordinates CCD File
D [auth A](2R,4R)-N~1~-(4-CHLOROPHENYL)-N~2~-[2-FLUORO-4-(2-OXOPYRIDIN-1(2H)-YL)PHENYL]-4-METHOXYPYRROLIDINE-1,2-DICARBOXAMIDE
C24 H22 Cl F N4 O4
QQBKAVAGLMGMHI-WIYYLYMNSA-N
CA

Query on CA



Download:Ideal Coordinates CCD File
C [auth A]CALCIUM ION
Ca
BHPQYMZQTOCNFJ-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.30 Å
  • R-Value Free:  0.296 (Depositor), 0.279 (DCC) 
  • R-Value Work:  0.260 (Depositor), 0.264 (DCC) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 56.483α = 90
b = 72.406β = 90
c = 77.715γ = 90
Software Package:
Software NamePurpose
DENZOdata reduction
SCALEPACKdata scaling
CNSrefinement
PDB_EXTRACTdata extraction

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2008-03-25
    Type: Initial release
  • Version 1.1: 2011-07-13
    Changes: Version format compliance
  • Version 1.2: 2017-10-18
    Changes: Advisory, Refinement description
  • Version 1.3: 2024-11-06
    Changes: Advisory, Data collection, Database references, Derived calculations, Structure summary